Frontiers in Oncology | Molecular and Cellular Oncology

Review

Published on 26 Jun 2025

Decoding estrogen receptor and GPER biology: structural insights and therapeutic advances in ERα−positive breast cancer

in Molecular and Cellular Oncology

Taniya Saha
Kiven Erique Lukong

Frontiers in Oncology

doi 10.3389/fonc.2025.1513225

154 views

Review

Published on 26 Jun 2025

The role of DNA methylation and demethylation in bladder cancer: a focus on therapeutic strategies

in Molecular and Cellular Oncology

Wiktoria Strasenburg
Jędrzej Borowczak
Daria Piątkowska
Jakub Jóźwicki
Dariusz Grzanka

Frontiers in Oncology

doi 10.3389/fonc.2025.1567242

146 views

Original Research

Accepted on 25 Jun 2025

Significance of FXa and its receptor PAR2 for the growth of colon cancer cells in vitro and in vivo

in Molecular and Cellular Oncology

Ulrike Meyer
Vincent Rönnpagel
Sophie Grammbauer
Mirjam von Lucadou
Ursula Rauch-Kröhnert
Edzard Schwedhelm
Frank Dombrowski
Christoph Ritter
Bernhard H. Rauch

Frontiers in Oncology

doi 10.3389/fonc.2025.1631350

Original Research

Published on 25 Jun 2025

Untargeted metabolomics revealed urinary metabolic pattern for discriminating prostate cancer from benign prostatic hyperplasia in Chinese participants

in Molecular and Cellular Oncology

Chenye Tang
Xiao Guo
Qian Zou
Xinghao Wang
Jian Sheng
Dan Shen
Chun Sun
Shuo Li
Ruilin Shen

Frontiers in Oncology

doi 10.3389/fonc.2025.1604169

279 views

Review

Published on 25 Jun 2025

Vaccine therapies for glioma: clinical frontiers and potential breakthrough

in Molecular and Cellular Oncology

Ying Xing
Caixia Liu
Yunfeng Feng
Shangyu Li
Yuping Chen

Frontiers in Oncology

doi 10.3389/fonc.2025.1613332

246 views

Original Research

Published on 25 Jun 2025

RBP7 knockdown inhibits proliferation of human hepatocellular carcinoma and activates the p38 MAPK pathway

in Molecular and Cellular Oncology

Jinhai Li
Huawei Zhai
Fujing Cai
Xian Zhang
Yu Zhou
Shuqun Li
Huachun Song
Haifeng Zhang
Guangzheng Sun
Minghui Zhu

Frontiers in Oncology

doi 10.3389/fonc.2025.1592616

191 views

Original Research

Published on 24 Jun 2025

CHMP6 as a novel prognostic biomarker in bladder cancer: insights from a comprehensive cell death-related gene risk model

in Molecular and Cellular Oncology

Wei Ning
Yan-Ru Yang
Chen-Xu Wu
Yue Hou
Zhi-Wei Liu
Chang-Bin Yang

Frontiers in Oncology

doi 10.3389/fonc.2025.1564826

354 views

Original Research

Published on 24 Jun 2025

p53 enhances elesclomol-Cu-induced cuproptosis in hepatocellular carcinoma via FDXR-mediated FDX1 upregulation

in Molecular and Cellular Oncology

Xiao Liu
Honglin Qu
Jingmin Li
Xuhong Sun
Zhenlin Wang
Dong Wang
Xianyong Bai
Xiaoyan Li

Frontiers in Oncology

doi 10.3389/fonc.2025.1584811

328 views

Correction

Accepted on 23 Jun 2025

Correction: Downregulation of PRKCI inhibits osteosarcoma cell growth by inactivating the Akt/mTOR signaling pathway

in Molecular and Cellular Oncology

Liujing Qu
Yu XIN
Jieni Feng
Xiaolei Ren
Zuming Li
Xueru CHEN
Guangyan Miao
Jiankun Chen
Chengming Sun
Yue Lu

Frontiers in Oncology

doi 10.3389/fonc.2025.1643772

Original Research

Published on 23 Jun 2025

CD16 and Siglec expression refine the phenotypic heterogeneity of steady-state myeloid-derived suppressor cells

in Molecular and Cellular Oncology

Chris D. St. Laurent
Zeinab Jame-Chenarboo
Alyssa E. Beck
Stacey Stubblefield
Shiteng Duan
Darren Sigal
Matthew S. Macauley

Frontiers in Oncology

doi 10.3389/fonc.2025.1570121

319 views

Original Research

Published on 23 Jun 2025

PP1γ promotes esophageal squamous cell carcinoma progression through the PP1γ/YAP1/SOX2 axis

in Molecular and Cellular Oncology

Juan Du
Li Liu
Shutao Zheng
Chenglu Dai
Jingyu Liu
Wei Zhang
Hongwei Pu
Jing Xue

Frontiers in Oncology

doi 10.3389/fonc.2025.1586679

399 views

Original Research

Published on 23 Jun 2025

Hsa_circ_0018909 promotes non-small cell lung cancer by directly regulating hsa-miR-513b-5p

in Molecular and Cellular Oncology

Qi Liu
Yong-Kui Yu
Hao-Miao Li
Wei Wang
Jing Xu

Frontiers in Oncology

doi 10.3389/fonc.2025.1542742

219 views

Review

Accepted on 20 Jun 2025

“Molecular Pigeon” Network of lncRNA and miRNA: Decoding Metabolic Reprogramming in Patients with Lung Cancer

in Molecular and Cellular Oncology

Mingxiao Li

Frontiers in Oncology

doi 10.3389/fonc.2025.1578927

Original Research

Published on 20 Jun 2025

MiR-221, miR-320a, miR133a, and miR-133b as potential biomarkers in leiomyosarcoma

in Molecular and Cellular Oncology

Mst Nasrin Akhtar
Annabell Walter
Kathrin Katenkamp
Yuan Chen
Thomas Lehmann
Wolfram Weschenfelder
Christian Spiegel
Matthias Vogt
Gunther O. Hofmann
Andreas Hochhaus

Frontiers in Oncology

doi 10.3389/fonc.2025.1577859

411 views

Review

Published on 19 Jun 2025

Research progress on FOXM1 in ovarian cancer diagnosis and therapeutics

in Molecular and Cellular Oncology

Xiao-Qing Tan
Ai-Ying Guo
Li-Fei Zheng
Jun Xiong

Frontiers in Oncology

doi 10.3389/fonc.2025.1598868

345 views

Case Report

Published on 18 Jun 2025

Case Report: Metastatic colorectal cancer with ALK–CEP44 fusion and rapid resistance development

in Molecular and Cellular Oncology

Silvan Hofmann
Claudine Egger
Silke Potthast
Martin Zoche
Andreas Wicki
Tarun Mehra

Frontiers in Oncology

doi 10.3389/fonc.2025.1613235

422 views